» Articles » PMID: 39263570

Sedative and Anxiolytic Effects of Duhamel: and Approaches with Phytochemical Profiling

Overview
Journal Front Pharmacol
Date 2024 Sep 12
PMID 39263570
Authors
Affiliations
Soon will be listed here.
Abstract

The World Health Organization reports that 30% of adults worldwide suffer from insomnia, while 10% of people worldwide suffer with various forms of anxiety. The significant negative effects of conventional medications used to treat anxiety and insomnia, such as abuse, addiction, amnesia, and cognitive and sexual dysfunction, have led to an increased preference for naturally derived substances with fewer side effects. Accordingly, in this study, the sedative and anxiolytic effects of -hexane, ethyl acetate (EtOAc), methanol (MeOH) and water extracts of the aerial parts of Duhamel., which is used for sedative purposes in folk medicine, were evaluated. To evaluate the sedative and anxiolytic effects of each extract, bioassay systems were used including traction and hole-board tests. The MeOH extract of was the most active extract on traction and hole-board tests compared to Diazepam. From the MeOH extract, major components were isolated, and their structures were identified as three flavonoid glycosides [rutin (1), quercetin-3--glucoside (2), and quercetin 3--rhamnoside (3)] using spectral techniques. The most abundant component was determined to be rutin, comprising 8 mg/100 mg dry extract in MeOH extract and 76.7 mg/100 mg dry fraction in fraction C using HPLC. The molecular docking studies evaluated the interaction of isolated flavonoid glycosides with the interaction energies and protein-ligand interaction details of the anxiety-related receptors GABAA and GABAB. For the GABAA receptor, quercetin-3--glucoside demonstrated the highest docking score. Quercetin-3--rhamnoside and rutin also show promising interactions, particularly with the GABAB receptor, highlighting their potential as modulators of these receptors. In conclusion, the use of for sedative purposes in folk medicine has been confirmed for the first time by studies, and its possible active compounds and sedative-anxiolytic mechanism have been determined through phytochemical and studies.

References
1.
Ishola I, Olayemi S, Yemitan O, Umeh E . Antidepressant and anxiolytic effects of the methanol root extract of Capparis thonningii: involvement of monoaminergic, cholinergic and GABAergic systems. Drug Res (Stuttg). 2014; 65(4):205-13. DOI: 10.1055/s-0034-1376963. View

2.
Pirintsos S, Panagiotopoulos A, Bariotakis M, Daskalakis V, Lionis C, Sourvinos G . From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples. Molecules. 2022; 27(13). PMC: 9268545. DOI: 10.3390/molecules27134060. View

3.
Jager A, Saaby L . Flavonoids and the CNS. Molecules. 2011; 16(2):1471-85. PMC: 6259921. DOI: 10.3390/molecules16021471. View

4.
Naziroglu M, Akay M, Celik O, Yildirim M, Balci E, Yurekli V . Capparis ovata modulates brain oxidative toxicity and epileptic seizures in pentylentetrazol-induced epileptic rats. Neurochem Res. 2013; 38(4):780-8. DOI: 10.1007/s11064-013-0978-3. View

5.
Rauf A, Rashid U, Masoud N, Akram Z, Saeed A, Muhammad N . In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3',4',7,8-tetrahydroxy-3-methoxyflavone isolated from . Drug Target Insights. 2024; 18:47-53. PMC: 11188735. DOI: 10.33393/dti.2024.2745. View